Inflammatory stimuli differentially modulate the transcription of paracrine signaling molecules of equine bone marrow multipotent mesenchymal stromal cells

Osteoarthritis and Cartilage

Volumn 21, Issue 8, 2013, Pages 1116-1124

  Vezina Audette R ^a   Lavoie Lamoureux, A ^a   Lavoie, J P ^a   Laverty, S ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cartilage; Equine; Horse; Mesenchymal stem cells; Multipotent mesenchymal stromal cells; Osteoarthritis; Paracrine communication; Reverse transcriptase polymerase chain reaction; Stem cells; Synovial fluid

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; INFLAMMATION; MESENCHYMAL STROMA CELL; MULTIPOTENT STEM CELL; NONHUMAN; OSTEOARTHRITIS; PARACRINE SIGNALING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; UPREGULATION;

CARTILAGE; EQUINE; HORSE; MESENCHYMAL STEM CELLS; MULTIPOTENT MESENCHYMAL STROMAL CELLS; OSTEOARTHRITIS; PARACRINE COMMUNICATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; SYNOVIAL FLUID;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HORSE DISEASES; HORSES; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MESENCHYMAL STROMAL CELLS; OSTEOARTHRITIS; PARACRINE COMMUNICATION; SYNOVIAL FLUID; TRANSCRIPTION, GENETIC;

EID: 84879879190     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.05.004     Document Type: Article

References (44)

1. Caplan A.I., Dennis J.E. Mesenchymal stem cells as trophic mediators. JCell Biochem 2006, 98(5):1076-1084.
2. Coleman C.M., Curtin C., Barry F.P., O'Flatharta C., Murphy J.M. Mesenchymal stem cells and osteoarthritis: remedy or accomplice?. Hum Gene Ther 2010, 21(10):1239-1250.
3. Raicevic G., Rouas R., Najar M., Stordeur P., Boufker H.I., Bron D., et al. Inflammation modifies the pattern and the function of toll-like receptors expressed by human mesenchymal stromal cells. Hum Immunol 2010, 71(3):235-244.
4. Yi T., Lee D.S., Jeon M.S., Kwon S.W., Song S.U. Gene expression profile reveals that STAT2 is involved in the immunosuppressive function of human bone marrow-derived mesenchymal stem cells. Gene 2012, 497(2):131-139.
5. Carrero R., Cerrada I., Lledo E., Dopazo J., Garcia-Garcia F., Rubio M.P., et al. IL1beta induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-kappaB. Stem Cell Rev 2012, 8(3):905-916.
6. Shi Y., Su J., Roberts A.I., Shou P., Rabson A.B., Ren G. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 2012, 33(3):136-143.
7. Phinney D.G., Prockop D.J. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007, 25(11):2896-2902.
8. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004, 109(10):1292-1298.
9. Crisostomo P.R., Wang Y., Markel T.A., Wang M., Lahm T., Meldrum D.R. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol 2008, 294(3):C675-C682.
10. Leijs M.J., van Buul G.M., Lubberts E., Bos P.K., Verhaar J.A., Hoogduijn M.J., et al. Effect of arthritic synovial fluids on the expression of immunomodulatory factors by mesenchymal stem cells: an explorative invitro study. Front Immunol 2012, 3:231.
11. Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J.P., Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011, 7(1):33-42.
12. Goldring M.B., Otero M., Tsuchimochi K., Ijiri K., Li Y. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis 2008, 67(Suppl 3):iii75-82.
13. Murphy J.M., Fink D.J., Hunziker E.B., Barry F.P. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003, 48(12):3464-3474.
14. Agung M., Ochi M., Yanada S., Adachi N., Izuta Y., Yamasaki T., et al. Mobilization of bone marrow-derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration. Knee Surg Sports Traumatol Arthrosc 2006, 14(12):1307-1314.
15. Frisbie D.D., Kisiday J.D., Kawcak C.E., Werpy N.M., McIlwraith C.W. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. JOrthop Res 2009, 27(12):1675-1680.
16. Roberts S., Genever P., McCaskie A., De Bari C. Prospects of stem cell therapy in osteoarthritis. Regen Med 2011, 6(3):351-366.
17. Endres M., Neumann K., Haupl T., Erggelet C., Ringe J., Sittinger M., et al. Synovial fluid recruits human mesenchymal progenitors from subchondral spongious bone marrow. JOrthop Res 2007, 25(10):1299-1307.
18. Zhang S., Muneta T., Morito T., Mochizuki T., Sekiya I. Autologous synovial fluid enhances migration of mesenchymal stem cells from synovium of osteoarthritis patients in tissue culture system. JOrthop Res 2008, 26(10):1413-1418.
19. Song H.Y., Lee M.J., Kim M.Y., Kim K.H., Lee I.H., Shin S.H., et al. Lysophosphatidic acid mediates migration of human mesenchymal stem cells stimulated by synovial fluid of patients with rheumatoid arthritis. Biochim Biophys Acta 2010, 1801(1):23-30.
20. Sekiya I., Muneta T., Koga H., Nimura A., Morito T., Shimaya M., et al. Articular cartilage regeneration with synovial mesenchymal stem cells. Clin Calcium 2011, 21(6):879-889.
21. Bourzac C., Smith L.C., Vincent P., Beauchamp G., Lavoie J.P., Laverty S. Isolation of equine bone marrow-derived mesenchymal stem cells: a comparison between three protocols. Equine Vet J 2010, 42(6):519-527.
22. Lavoie-Lamoureux A., Beauchamp G., Quessy S., Martin J.G., Lavoie J.P. Systemic inflammation and priming of peripheral blood leukocytes persist during clinical remission in horses with heaves. Vet Immunol Immunopathol 2012, 146(1):35-45.
23. Farley J., Sirois J., MacFarlane P.H., Kombe A., Laverty S. Evaluation of coexpression of microsomal prostaglandin E synthase-1 and cyclooxygenase-2 in interleukin-1-stimulated equine articular chondrocytes. Am J Vet Res 2005, 66(11):1985-1991.
24. Romieu-Mourez R., Francois M., Boivin M.N., Bouchentouf M., Spaner D.E., Galipeau J. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. JImmunol 2009, 182(12):7963-7973.
25. Montzka K., Fuhrmann T., Muller-Ehmsen J., Woltje M., Brook G.A. Growth factor and cytokine expression of human mesenchymal stromal cells is not altered in an invitro model of tissue damage. Cytotherapy 2010, 12(7):870-880.
26. Waterman R.S., Tomchuck S.L., Henkle S.L., Betancourt A.M. Anew mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PloS One 2010, 5(4):e10088.
27. de Caestecker M.P., Telfer B.A., Hutchinson I.V., Ballardie F.W. The detection of intracytoplasmic interleukin-1 alpha, interleukin-1 beta and tumour necrosis factor alpha expression in human monocytes using two colour immunofluorescence flow cytometry. JImmunol Methods 1992, 154(1):11-20.
28. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258(5089):1798-1801.
29. Smirnova I., Poltorak A., Chan E.K., McBride C., Beutler B. Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol 2000, 1(1). RESEARCH002.
30. Trumble T.N., Trotter G.W., Oxford J.R., McIlwraith C.W., Cammarata S., Goodnight J.L., et al. Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses. Am J Vet Res 2001, 62(9):1467-1477.
31. Fernandes J.C., Martel-Pelletier J., Pelletier J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002, 39(1-2):237-246.
32. Kamm J.L., Nixon A.J., Witte T.H. Cytokine and catabolic enzyme expression in synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi. Equine Vet J 2010, 42(8):693-699.
33. Dunne A., O'Neill L.A. The interleukin-1 receptor/toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003, 2003(171):re3.
34. Song H.Y., Kim M.Y., Kim K.H., Lee I.H., Shin S.H., Lee J.S., et al. Synovial fluid of patients with rheumatoid arthritis induces alpha-smooth muscle actin in human adipose tissue-derived mesenchymal stem cells through a TGF-beta1-dependent mechanism. Exp Mol Med 2010, 42(8):565-573.
35. Yang K.G., Saris D.B., Verbout A.J., Creemers L.B., Dhert W.J. The effect of synovial fluid from injured knee joints on invitro chondrogenesis. Tissue Eng 2006, 12(10):2957-2964.
36. Hegewald A.A., Ringe J., Bartel J., Kruger I., Notter M., Barnewitz D., et al. Hyaluronic acid and autologous synovial fluid induce chondrogenic differentiation of equine mesenchymal stem cells: a preliminary study. Tissue Cell 2004, 36(6):431-438.
37. van de Loo F.A., Kuiper S., van Enckevort F.H., Arntz O.J., van den Berg W.B. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice. Am J Pathol 1997, 151(1):177-191.
38. Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011, 1813(5):878-888.
39. Goldring M.B., Otero M., Plumb D.A., Dragomir C., Favero M., El Hachem K., et al. Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur Cells Mater 2011, 21:202-220.
40. Spanholtz T.A., Theodorou P., Holzbach T., Wutzler S., Giunta R.E., Machens H.G. Vascular endothelial growth factor (VEGF165) plus basic fibroblast growth factor (bFGF) producing cells induce a mature and stable vascular network - a future therapy for ischemically challenged tissue. JSurg Res 2011, 171(1):329-338.
41. Mastri M., Shah Z., McLaughlin T., Greene C.J., Baum L., Suzuki G., et al. Activation of toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency. Am J Physiol Cell Physiol 2012, 303(10):C1021-C1033.
42. Boomsma R.A., Geenen D.L. Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis. PloS One 2012, 7(4):e35685.
43. Zisa D., Shabbir A., Suzuki G., Lee T. Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair. Biochem Biophys Res Commun 2009, 390(3):834-838.
44. Kinnaird T., Stabile E., Burnett M.S., Shou M., Lee C.W., Barr S., et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004, 109(12):1543-1549.